The FDA recently stopped the publication of several studies about the safety of Covid and shingles vaccines. This was confirmed by a spokesperson from the Health and Human Services (HHS) Department.
This action aligns with a broader trend under the Trump administration to question the effectiveness of these vaccines. Since Robert F. Kennedy Jr., a well-known vaccine skeptic, took the helm at HHS, there’s been a noticeable shift in guidance. Recommendations for Covid shots have softened, research into vaccine development has declined, and there have been attempts to change the childhood vaccination schedule.
FDA scientists previously analyzed millions of patient records, revealing that side effects from these vaccines are quite rare. However, in October, they had to withdraw two studies that were set for publication in medical journals. Additionally, abstracts for a shingles vaccine study were not approved for a drug safety conference earlier this year.
The HHS spokesperson explained that these studies were withdrawn because the conclusions didn’t match the data. They emphasized that the FDA’s actions aimed to maintain a high standard for scientific integrity.
This situation reflects a growing skepticism surrounding vaccines, which has become a hot topic on social media. Many users express frustration over the conflicting information and changes in health guidelines.
For a broader perspective, a survey by the Pew Research Center in 2022 found that about 72% of Americans believe vaccines are safe, though this represents a slight decline from previous years. Understanding these shifts can help contextualize the current debates in public health.
The World Health Organization also points out that vaccine hesitancy has increased globally, driven by misinformation and public distrust. The ongoing discourse around vaccine safety is not just a U.S. issue; it resonates worldwide, illustrating the need for clear and consistent communication from health authorities.
For further reading on vaccine safety and efficacy, the CDC provides ongoing updates and resources tailored to the public’s needs.
Source link
Breaking News: Business,Health care industry,Pharmaceuticals,Biotech and Pharmaceuticals,Biotechnology,Business,Robert F. Kennedy Jr.,GSK plc,business news
